Observational Study About Patients Diagnosed With NAFLD

Recruiting now

Conditions studied: Nonalcoholic Fatty Liver Disease

In brief

Nonalcoholic fatty liver disease (NAFLD) is the most common condition affecting the liver, owing to its association with obesity and the metabolic syndrome. The largest study to date using magnetic resonance spectroscopy to quantify liver triglyceride (TG) content showed that approximately 33% of individuals have hepatic steatosis. NAFLD encompasses a continuum of histological findings that starts with steatosis that can progress to nonalcoholic steatohepatitis (NASH), which is characterized by inflammation and cell death, and eventually cirrhosis. Given the large number of individuals afflicted with this condition, there is a clear need to develop effective and safe therapies to treat NAFLD.

Key facts

Study ID

NCT05625750

Run by

Xiangya Hospital of Central South University

People needed

500

Starts

2022-04-27

Expected to finish

2027-04-27

Last updated by the study team

2022-11-30

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• patients diagnosed with nonalcoholic fatty liver disease

You may not qualify if…

• patients suspected of excessive alcohol consumption
• malignant tumors, dementia, active tuberculosis, AIDS, organ failure, pregnancy or breastfeeding, etc cannot cooperate with the investigation
• incomplete data such as HBV serological results and abdominal ultrasound results
• patients who refuse to sign informed consent

Where it is running

• Department of Infectious Disease, Xiangya Hospital, Central South University — Changsha, Hunan, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.